載入...
Tumor response and clinical toxicity associated with second-line chemotherapy regimens for advanced non-squamous non-small cell lung cancer: A retrospective cohort study
BACKGROUND: Previously reported superior tumor response of pemetrexed in the second-line setting for advanced non-squamous non-small cell lung cancer (advNS-NSCLC) has never been confirmed in real-world studies. Platinum-based doublet is frequently used in the second-line setting for advanced NSCLC...
Na minha lista:
發表在: | Thorac Cancer |
---|---|
Main Authors: | , , , , , , , , , , , |
格式: | Artigo |
語言: | Inglês |
出版: |
BlackWell Publishing Ltd
2014
|
主題: | |
在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4704368/ https://ncbi.nlm.nih.gov/pubmed/26767027 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/1759-7714.12102 |
標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|